A trial to assess metformin, alone vs in combination with linagliptin, in patients with type 2 diabetes who were previously treated with metformin but discontinued treatment due to gastrointestinal intolerance.
Phase of Trial: Phase IV
Latest Information Update: 22 Nov 2014
At a glance
- Drugs Linagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 22 Nov 2014 New trial record
- 17 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.